Oral Agents in the Treatment of Type 2 Diabetes:
The New Frontier Pharmacists January 15, 2015

Knowledge

Goal

To provide continuing professional development for pharmacists.

Subject Description

Type 2 Diabetes Treatment

Learning Objectives

  1. Explain the mechanism of action, indications, and side-effect profile of oral antidiabetic agents for the treatment of type 2 diabetes.
  2. Describe the medications in each therapeutic class and their role in treating type 2 diabetes
  3. List the advantages and disadvantages of medications within each drug class.
  4. Identify an appropriate agent based on patient comorbidities and preferences.

Target Audience

This program has been developed for pharmacists working in the health-system and related pharmacy settings.

Activity Type

knowledge

Author / Speaker

Maabo Kludze-Forson, PharmD, MBA, CDE, BCPS
Senior Clinical Pharmacy Specialist, Greater New York Hospital Association

Clinical Reviewers

Joseph Pinto, BS, MS
Heide Christiansen, PharmD
Jill Bleyl, CE Administrator

Additional Information

ACPE: 0134-9999-14-211-L01-P
Contact Hour: 1
CEUs: 0.1
Presented At: Jan 15, 2015
Expires At: Jan 15, 2018 at 12:00 am CT the day of
ACPE Renewal Pending

Accreditation Council for Pharmacy Education


NYSCHP

NYC Chapter Oral Agents in the Treatment of Type 2 Diabetes: The New Frontier January 15, 2015

New York State Council of Health-system Pharmacists

Please sign in to continue →

Are you new to the site?

Sign up today for all the benefits membership has to offer!

Registration is quick and easy!

Questions or Comments

Please contact
New York State Council of Health-system Pharmacists →

Share to… Facebook Twitter LinkedIn Pinterest Google+ Share via Email